Concourse Financial Group Securities’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10388 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10149 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9914 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9666 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9446 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9088 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9097 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8904 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8735 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8535 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8247 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7813 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7449 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7130 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6844 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6596 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6430 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6324 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6239 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6086 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6076 |
|